Ameritas Investment Partners’s Epizyme, Inc EPZM Stock Holding History

Ameritas Investment Partners’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-7,880	Closed	-$9K	–	3354
2022 Q1	$9K	Hold	7,880	–	–	﹤0.01%	2847
2021 Q4	$20K	Hold	7,880	–	–	﹤0.01%	2667
2021 Q3	$40K	Hold	7,880	–	–	﹤0.01%	2318
2021 Q2	$65K	Hold	7,880	–	–	﹤0.01%	2016
2021 Q1	$69K	Hold	7,880	–	–	﹤0.01%	1891
2020 Q4	$86K	Hold	7,880	–	–	﹤0.01%	1663
2020 Q3	$94K	Hold	7,880	–	–	﹤0.01%	1468
2020 Q2	$127K	Buy	7,880 +931	+13%	+$16.3K	0.01%	1268
2020 Q1	$108K	Buy	6,949 +296	+4%	+$6.36K	0.01%	1223
2019 Q4	$164K	Hold	6,653	–	–	0.01%	1217
2019 Q3	$69K	Hold	6,653	–	–	﹤0.01%	1690
2019 Q2	$83K	Buy	6,653 +1,723	+35%	+$22.2K	﹤0.01%	1622
2019 Q1	$61K	Buy	4,930 +750	+18%	+$8.38K	﹤0.01%	1770
2018 Q4	$26K	Hold	4,180	–	–	﹤0.01%	2194
2018 Q3	$44K	Hold	4,180	–	–	﹤0.01%	2067
2018 Q2	$57K	Hold	4,180	–	–	﹤0.01%	1902
2018 Q1	$74K	Hold	4,180	–	–	﹤0.01%	1683
2017 Q4	$52K	Buy	4,180 +938	+29%	+$13.6K	﹤0.01%	1913
2017 Q3	$56K	Hold	3,242	–	–	﹤0.01%	1830
2017 Q2	$49K	Hold	3,242	–	–	﹤0.01%	1922
2017 Q1	$56K	Buy	+3,242	New	+$43.2K	﹤0.01%	1771

Other funds holding EPZM

RP Management New York $139M AUM 37.98% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ameritas Investment Partners's EPZM Position: Q2 2022 in Review

Ameritas Investment Partners sold out of Epizyme, Inc (EPZM) in Q2 2022, closing a stake of 7,880 shares — an estimated $9K sold.

Ameritas Investment Partners first reported a position in EPZM in Q1 2017 and held it in 21 quarters. The position peaked at $164K in Q4 2019. 93 funds tracked by Wall St. Rank hold EPZM as of Q2 2022.

Ameritas Investment Partners reported no remaining Epizyme, Inc position as of Q2 2022 after selling out during the quarter.
Ameritas Investment Partners sold 7,880 Epizyme, Inc shares in Q2 2022, an estimated $9K.
Ameritas Investment Partners first reported a position in Epizyme, Inc in Q1 2017 and held it in 21 quarters.
Ameritas Investment Partners's Epizyme, Inc position peaked at $164K in Q4 2019.
93 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2022.

Based on Ameritas Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.